DrugDashboards

Chloroquine Phosphate

chloroquine phosphate · CHLOROQUINE PHOSPHATE 500 mg/1 · Tablet, Coated · Oral · Chartwell RX, LLC

NDC 62135-0717-26 · 25 TABLET, COATED in 1 BOTTLE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is up 25% over the past year, to $6.74 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$6.74per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$4.12per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$5.76per TABweighted avg manufacturer price $1.1219 · Apr 1, 202685% of what pharmacies pay — a deeper discount than 95% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.50$5.00$7.50Jul 2024Sep 2026$6.74
20 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$202.24
#90 count
$606.71

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for chloroquine phosphate (oral solid) in the next 90 days

price up 17% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA214756
TE code
AA
Approval date
Sep 3, 2021
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of chloroquine phosphate (Tablet, Coated)

LabelerStrengthFirst seenLast seen
Avet Pharmaceuticals Inc.CHLOROQUINE PHOSPHATE 500 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCCHLOROQUINE PHOSPHATE 500 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Chloroquine Phosphate — NDC 62135-0717-26," retrieved September 3, 2026, https://drugdashboards.com/drug/62135071726.

Free to cite with attribution — see how the data is put together.